![profile-img](https://pbs.twimg.com/profile_images/1508540483819249669/CFFrrRsP_200x200.jpg)
Pooja S. Jagadish, MD
@PoojaJagadishMD
To be a good cardiologist, one must be a great internist.
Cardiologist & Clinical Educator
π«@UAZHeart | IM @UTHSC | MD @ETSU
ξ¨ β medical advice |ξ¨ β employer's
28-03-2022 20:13:41
1,7K Tweets
1,6K Followers
747 Following
![Pooja S. Jagadish, MD(@PoojaJagadishMD) 's Twitter Profile Photo Pooja S. Jagadish, MD(@PoojaJagadishMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1508540483819249669/CFFrrRsP_200x200.jpg)
Continue beta-blockers during pregnancy and in the post-partum period in those with syndromic aortophathies (e.g. Marfan, vascular EDS) or nsHTAD (Class I).
- Risk of fetal growth impairment
- Labetalol is preferred
- Avoid CCB, ACEI, ARB
#CVBoardPearl #MedTwitter #CardioOB
![Pooja S. Jagadish, MD (@PoojaJagadishMD) on Twitter photo 2024-04-29 15:00:08 Continue beta-blockers during pregnancy and in the post-partum period in those with syndromic aortophathies (e.g. Marfan, vascular EDS) or nsHTAD (Class I). - Risk of fetal growth impairment - Labetalol is preferred - Avoid CCB, ACEI, ARB #CVBoardPearl #MedTwitter #CardioOB Continue beta-blockers during pregnancy and in the post-partum period in those with syndromic aortophathies (e.g. Marfan, vascular EDS) or nsHTAD (Class I). - Risk of fetal growth impairment - Labetalol is preferred - Avoid CCB, ACEI, ARB #CVBoardPearl #MedTwitter #CardioOB](https://pbs.twimg.com/media/GMV0csgWkAAc4_3.jpg)